Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $767K (6,471 shares) of GLAUKOS Corp on Feb 19, 2026. Filing
- Last sale before this period: Aug 8, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | Director | Jun 24, 2015 | Jun 23, 2026 |
| Staar Surgical Co (STAA) | Former Director | Jun 17, 2022 | Jun 24, 2024 |
| Edwards Lifesciences (EW) | Former CVP, General Counsel | Feb 14, 2011 | May 11, 2012 |
Also a director at
Staar Surgical Co (STAA) (no filing in the last 18 months)
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 28, 2026, GLAUKOS Corp: 1,878 shares granted. 1 filing: 1
- Feb 19, 2026, GLAUKOS Corp: sold 15,000 shares for $1.8M, no plan disclosed; 1,960 shares moved between their own holdings; 15,000 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Jan 2, 2026, GLAUKOS Corp: 623 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.